WASHINGTON (dpa-AFX) - Medical technology firm Zimmer Biomet Holdings, Inc.
(ZBH) announced Thursday the U.S. Food and Drug Administration (FDA) 510(k)
clearance of the ROSA Shoulder System for robotic-assisted shoulder replacement
surgery.

ROSA Shoulder is the world's first robotic surgery system for shoulder
replacement, and the fourth application for the Company's comprehensive ROSA
Robotics portfolio, which includes the ROSA Knee System for total knee
arthroplasty and ROSA Hip System for total hip replacement.

ROSA Shoulder strengthens Zimmer Biomet's innovative shoulder implant portfolio,
which includes the Identity Shoulder System, and joins ZBEdge Dynamic
Intelligence, which has the power to enhance the company's cutting-edge digital
technologies, robotics and implant solutions.

ROSA Shoulder is designed to give surgeons the flexibility to execute a total
shoulder replacement using anatomic or reverse techniques and to enable precise
placement for improved outcomes.

ROSA Shoulder will be commercially available in the U.S. in the second half of
2024, and will work with the mymobility Digital Care Management Platform to
bolster the ZBEdge Dynamic Intelligence portfolio for patients undergoing
shoulder replacement surgery.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX